Mirum Pharmaceuticals Inc. files SEC Form 4

au.investing.com

Mirum Pharmaceuticals Inc. filed a Form 4 with the SEC on July 8, 2026. The filing likely details changes in beneficial ownership of securities by company insiders. This is a standard regulatory requirement for public companies. Such filings can provide insights into insider trading activity and corporate governance.


With a significance score of 0.8, this news ranks in the top 87% of today's 30997 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Mirum Pharmaceuticals Inc. files SEC Form 4 | News Minimalist